Medical Pulp and Associated Products 2023

Award

Buyers

Value

£105,000,000

Suppliers

Classifications

  • Pulp
  • Devices for the elderly
  • Devices for the disabled
  • Plastic products
  • Medical consumables
  • Macerators for the treatment of sewage
  • Machinery for cleaning, filling, packing or wrapping bottles or other containers

Tags

  • award
  • contract

Published

2 years ago

Description

Non-exclusive framework agreement for the supply of Disposable Medical Pulp, Medical Pulp Support Products, Macerators, Bedpan Washers and Absorbent products for use with Medical Pulp via the Stock, Blue Diamond, eDirect or Direct route to market.  This framework agreement will have an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months. 
It Is anticipated that in the first 24 months of the framework agreement the value of purchases will be circa GBP 52 500 000 and if extended the 4-year purchase value will be in the region of GBP 105 000 000, however this is approximate only and includes a forecast for growth. The values may vary depending on the requirements of those bodies purchasing under the framework agreement.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Total Patient Assessment Device Solutions Tender Notice

NHS Supply Chain seeks to establish a Framework Agreement for Total Patient Assessment Device Solution Products under which it will be entitled to purchase supplies and/or services which it will make available for purchase by 1) any NHS Trust; 2) any other NHS entity; 3) any government department, agency or other statutory body and/or 4) any private sector entity active in the UK healthcare sector. Only NHS Supply Chain can order from the Framework Agreement and enter into contracts under it. This includes the following requirements which have been sub-divided into Lots: Lot 1 - Blood Pressure Monitoring with Blood Pressure Cuffs Lot 2 - Thermometer Devices and Related Consumables Lot 3 - Patient Weighing Scales and Measuring Devices Lot 4 - Patient Assessment Devices and Kits Lot 5 - Personal Health Monitors and Kits It is anticipated that initial expenditure will be in the region of £23,900,000 to £25,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated value over the 2-year Framework Agreement will be in the region of £47,800,000. There will be an option to extend the Framework for a further 2 years. If the extension period will be utilised, then the total value of the Framework across the 4 year would be approximately £95,600,000. Preliminary market engagement was carried out during PCR 2015, with a Prior Information Notice being published. The identifier codes for the Prior information Notice are as follows: Notice identifier: 2024/S 000-018940 Procurement identifier (OCID): ocds-h6vhtk-04713a

Katy Reed

Katy Reed

Published 9 hours ago
Open

Supply and Support of Complete Antibody Quantification Testing Systems

The RCI laboratories in NHSBT provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig This specialised test conducted in 4 of the 7 RCI laboratories (namely Birmingham, Colindale, Liverpool and Newcastle). RCI processes approximately 10,000 tests annually. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals.

Katy Reed

Katy Reed

Published 3 days ago
Open

Fibreplast and Gel Bolus

materials used in radiotherapy to help deliver radiation more accurately and effectively to the target area.

Katy Reed

Katy Reed

Published 3 days ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

NHS Supply Chain operated by North of England Commercial Procurement Collaborative (who are hosted by Leeds and York Partnership NHS Foundation Trust) acting on behalf of Supply Chain Coordination Ltd

National or federal agency/office

Kirsty Dodson

[email protected]

Timeline complete

Publish
Bid
Evaluate
Award
Complete